Vitrectomia transconjuntival 25 gauge via pars plana para opacidade vítrea persistente em pacientes com implante de lentes multifocais / Transconjunctival sutureless 25-gauge vitrectomy for visually significant vitreous floaters in patients with multifocal intraocular lens

OBJETIVO: O objetivo do presente estudo é relatar o resultado visual obtido após realização de vitrectomia via pars plana 25 gauge (VVPP-25-gauge) em pacientes com opacidades vítreas persistentes e debilitantes previamente submetidos à cirurgia de facectomia com implante de lente intraocular (LIO) multifocal. MÉTODOS: Estudo prospectivo de 14 olhos com implante de LIO multifocal e presença de opacidade vítrea submetidos à VVPP-25-gauge. Foram avaliados acuidade visual sem correção (AVSC), acuidade visual com correção (AVCC) para longe, acuidade visual para perto corrigida para longe (AVPC) e equivalente esférico (EE) antes e 3 meses pós-vitrectomia. Um questionário de satisfação e melhora visual foi administrado antes e após a realização da vitrectomia para avaliar a satisfação dos pacientes. RESULTADO: Após três meses da VVPP25-gauge, a média das acuidades (logMAR) era: AVSC, 0,10 ± 0,14;AVCC, 0,02 ± 0,08;AVPC, 0,00 ± 0,0; EE, +0,16 ± 0,34. Treze olhos (92,9 por cento) apresentavam AVSC de 20/40 ou melhor, e 11 (78,5 por cento) de 20/25 ou melhor. Dez (90,9 por cento) pacientes demonstraram satisfação com o procedimento cirúrgico, obtendo eliminação de todos os floaters em 13 olhos (92,8 por cento). Apenas um paciente apresentou insatisfação com o resultado visual final devido ao aparecimento de edema macular cistóide pós-vitrectomia. CONCLUSÃO: A remoção das opacidades vítreas, usando a VVPP-25-gauge se mostrou segura, e resultou em alto nível de satisfação dos pacientes, com resolução dos sintomas na sua quase totalidade, e uma melhora subjetiva da qualidade funcional da visão.

PURPOSE: The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation. METHODS: Fourteen eyes of 11 patients with multifocal IOL implant associated with vitreous opacities that underwent 25-gauge vitrectomy were prospectively analyzed. Information collected included near (UCNVA) and distance uncorrected visual acuity (UCDVA), best corrected distance visual acuity (BCDVA), and the spherical equivalent (SE) before and 3 months after vitrectomy. Patients were questioned about surgery satisfaction and visual improvement after vitrectomy. RESULTS: Three months after 25-gauge TSV the mean visual acuities were: UCDVA, 0,10 ± 0,14; BCDVA, 0,02 ± 0,08; UCNVA, 0,00 ± 0,0; SE, +0,16 ± 0,34. Thirteen eyes (92.9 percent) had a UCDVA of 0.5 (20/40) or better, and 11 (78.5 percent) achieved a UCDVA of 0.8 (20/25) or better. Ten (90.9 percent) patients demonstrated satisfaction with surgery, and floaters have gone away in thirteen eyes (92.8 percent), while one patient expressed no satisfaction with her postoperative visual acuity because of the cystoid macular edema that occurred. CONCLUSION: 25-gauge TSV was a safe and accurate option for patients with multifocal lens and visual disturbing vitreous floaters providing subjective improvement of symptoms.

Multifocal intraocular lens optic anteriorization capture to correct residual refractive error.

PURPOSE: To evaluate the efficacy and safety of capturing the intraocular lens (IOL) optic through the anterior capsulorhexis opening in eyes with multifocal IOLs and a residual refractive error. SETTING: Hospital Oftalmológico de Brasília, Brasília, Brazil. METHODS: Eyes with previous cataract surgery and Tecnis ZM900 multifocal IOL implantation were prospectively analyzed. After at least 1 month, patients had second surgery in which the IOL optic was captured through the anterior capsulorhexis opening to correct the residual refractive error. Preoperative and postoperative examinations at 1 day and 3 months included spherical equivalent (SE); uncorrected distance (UDVA), near (UNVA), and intermediate (UIVA) visual acuities; and corrected distance visual acuity (CDVA). RESULTS: The study included 16 eyes of 14 patients. The mean UDVA was 0.32 logMAR preoperatively and 0.10 logMAR after anterior optic capture and the mean SE, +1.09 diopters (D) and +0.26 D, respectively; both improvements were statistically significant (P<.001). The change in CDVA and UNVA from before anterior optic capture to the last follow-up was not statistically significant. The UIVA was significantly worse postoperatively (P = .011). No eye lost lines of CDVA. One eye (6.25%) developed glaucoma postoperatively. At the last follow-up, 13 patients (92.85%) were spectacle-independent for near and distance vision. CONCLUSION: Early outcomes indicate that anterior optic capture is a safe, accurate procedure in eyes with multifocal IOLs and a mild hyperopic residual refractive error postoperatively.

Pars plana vitrectomy and silicone oil tamponade for acute endophthalmitis treatment.

PURPOSE: To evaluate the outcomes of pars plana vitrectomy and silicone oil injection for the treatment of infectious endophthalmitis. METHODS: 35 cases of endophthalmitis secondary to phacoemulsification (20 patients), trabeculectomy (8 patients), perforating trauma (2 patients), trauma (2 patients), corneal transplantation (1 patient), vitrectomy (1 patient) and corneal ulceration (1 patient) were retrospectively studied. Patients were separated into two groups: Group 1 (n=24): intravitreal antibiotic injection, associated with topical and oral antibiotics; Group 2 (n=11): vitrectomy with intravitreal antibiotic injection and silicone oil injection. The follow-up ranged from 1 to 48 months (mean of 16 months). RESULTS: From 24 patients in group 1, 11 patients (45.83%), had infection controlled with intravitreal antibiotic injection only; 13 patients (54.15%) regressed to uncontrolled endophthalmitis, in which two patients (8.33%) were submitted to evisceration and one patient (4.16%) had corneal melting. The remaining 10 patients (41.66%) with uncontrolled endophthalmitis were submitted to pars plana vitrectomy and silicone oil injection. Six patients (25%) from Group I had retinal detachment during the first month of follow-up and also required pars plana vitrectomy and silicone oil injection. In Group 2 patients (n=11), all of them had controlled infection at the first procedure. In one case (9.09%), a severe proliferative vitreoretinopathy induced loss of vision. CONCLUSION: These results suggest that silicone oil tamponade might be beneficial in the treatment strategy of infectious endophthalmitis.

Pars plana vitrectomy and silicone oil tamponade for acute endophthalmitis treatment / Vitrectomia pars plana e tamponamento por óleo de silicone para o tratamento de endoftalmite aguda

PURPOSE: To evaluate the outcomes of pars plana vitrectomy and silicone oil injection for the treatment of infectious endophthalmitis. METHODS: 35 cases of endophthalmitis secondary to phacoemulsification (20 patients), trabeculectomy (8 patients), perforating trauma (2 patients), trauma (2 patients), corneal transplantation (1 patient), vitrectomy (1 patient) and corneal ulceration (1 patient) were retrospectively studied. Patients were separated into two groups: Group 1 (n=24): intravitreal antibiotic injection, associated with topical and oral antibiotics; Group 2 (n=11): vitrectomy with intravitreal antibiotic injection and silicone oil injection. The follow-up ranged from 1 to 48 months (mean of 16 months). RESULTS: From 24 patients in group 1, 11 patients (45.83 percent), had infection controlled with intravitreal antibiotic injection only; 13 patients (54.15 percent) regressed to uncontrolled endophthalmitis, in which two patients (8.33 percent) were submitted to evisceration and one patient (4.16 percent) had corneal melting. The remaining 10 patients (41.66 percent) with uncontrolled endophthalmitis were submitted to pars plana vitrectomy and silicone oil injection. Six patients (25 percent) from Group I had retinal detachment during the first month of follow-up and also required pars plana vitrectomy and silicone oil injection. In Group 2 patients (n=11), all of them had controlled infection at the first procedure. In one case (9.09 percent), a severe proliferatative vitreoretinopathy induced loss of vision. CONCLUSION: These results suggest that silicone oil tamponade might be beneficial in the treatment strategy of infectious endophthalmitis.

OBJETIVO: Avaliar os resultados da vitrectomia pars plana com tamponamento com óleo de silicone no tratamento de endoftalmite aguda. MÉTODOS: Trinta e cinco pacientes com endoftalmite, sendo 20 secundário à facoemulsificação, 8 por trabeculectomia, 2 por trauma perfurante, 2 por trauma, 1 por transplante de córnea, 1 por vitrectomia, e 1 por úlcera de córnea, foram estudados retrospectivamente. Os pacientes foram separados em dois grupos. Grupo 1 (n=24): injeção de antibiótico intravítreo (AIV), associado com antibióticos oral e sistêmico; Grupo 2 (n=11): vitrectomia com AIV e óleo de silicone. O seguimento variou de 1 a 48 meses (média de 16 meses). RESULTADOS: Dos 24 pacientes no Grupo 1, 11 (45,83 por cento) tiveram controle da infecção apenas com injeção AIV, 13 (54,15 por cento) não controlaram a endoftalmite, sendo que, dois destes (8,33 por cento) foram submetidos à evisceração e um (4,16 por cento) evoluiu para "melting" corneano. Os outros 10 (41,66 por cento) pacientes foram submetidos à vitrectomia pars plana e óleo de silicone. Seis pacientes (25 por cento) do Grupo 1 tiveram descolamento de retina e também necessitaram de vitrectomia pars plana e óleo de silicone. No Grupo 2 (n=11), todos tiveram controle da infecção no primeiro procedimento e não necessitaram de mais intervenções, exceto pela remoção do óleo de silicone três meses depois. CONCLUSÃO:Os resultados sugerem que o tamponamento por óleo de silicone parece ser benéfico na estratégia de tratamento da endoftalmite infecciosa aguda.

Intravenous sodium fluorescein enhances the visibility of vitreous during vitrectomy surgery for diabetic retinopathy / Fluoresceína sódica intravenosa aumenta a visibilidade do vítreo durante a cirurgia de vitrectomia para retinopatia diabética

OBJECTIVE: To observe the effectiveness of intravenous sodium fluorescein visibility in the vitreous during vitrectomy surgery in patients with diabetic retinopathy. METHODS: Fourteen consecutive cases of vitreoretinal surgery for vitreous hemorrhage and tractional retinal detachment secondary to diabetic retinopathy underwent intravenous injection of sodium fluorescein to 20 percent 1 hour before the surgery. The images of the steps of the surgeries were recorded. RESULTS: The sodium fluorescein stained green from the vitreous peripheral, vitreous base, posterior hyaloid, further improving visibility to a complete and more secure vitrectomy. The sodium fluorescein also stained fibrous points (sites of neovascularization) with high intensity making it easier its visibility. No complications associated with the dye injection were observed in all cases. CONCLUSION: Intravenous sodium fluorescein can be used safely for facilitating the observation of the vitreous, vitreous base, posterior hyaloid and sites of neovascularization. This technique can facilitate the process of vitrectomy in patients with diabetic retinopathy.

OBJETIVO: Observar a eficácia da fluoresceína sódica intravenosa, na visibilidade do vítreo, durante a cirurgia de vitrectomia nos pacientes com retinopatia diabética. MÉTODOS: Quatorze casos consecutivos de cirurgia vitreorretiniana para hemorragia vítrea e descolamento tracional da retina secundário à retinopatia diabética, foram submetidos à injeção de fluoresceína intravenosa a 20 por cento, 1 hora antes da cirurgia.As imagens de todos os passos das cirurgias foram gravadas. RESULTADOS: A fluoresceína corou de verde o vítreo periférico, base vítrea, hialóide posterior melhorando a visibilidade para uma vitrectomia completa e mais segura. A fluoresceína também corou pontos fibrosos (sítios de neovascularização) com alta intensidade tornando mais fácil sua observação. Nenhuma complicação associada com a injeção do contraste foi observada. CONCLUSÃO: Fluoresceína sódica intravenosa pode ser usada de forma segura para facilitar a observação do vítreo, base vítrea, hialóide posterior e sítios de neovascularização. Esta técnica pode facilitar o procedimento de vitrectomia em pacientes com retinopatia diabética.